Literature DB >> 24787379

Screening history of cervical cancers in Emilia-Romagna, Italy: defining priorities to improve cervical cancer screening.

Paolo Giorgi Rossi1, Stefania Caroli, Silvia Mancini, Priscilla Sassoli de' Bianchi, Alba C Finarelli, Carlo Naldoni, Lauro Bucchi, Fabio Falcini.   

Abstract

Most invasive cervical cancers in industrialized countries are due to the lack of Pap test coverage, very few are due to screening failures. This study aimed at quantifying the proportion of invasive cancers occurring in nonscreened or underscreened women and that in women with a previous negative screening, that is, screening failure, during the first two screening rounds (1996-2002) and in the following rounds (2003-2008) in the Emilia-Romagna region. All cases of invasive cancers registered in the regional cancer registry between 1996 and 2008 were classified according to screening history through a record linkage with the screening programme registry. The incidence significantly decreased from 11.6/100 000 to 8.7/100 000; this decrease is due to a reduction in squamous cell cancers (annual percentage change -6.2; confidence interval: -7.8, -4.6) and advanced cancers (annual percentage change -6.6; confidence interval: -8.8, -4.3), whereas adenocarcinomas and microinvasive cancers were essentially stable. The proportion of cancers among women not yet invited and among nonresponders decreased over the two periods, from 45.5 to 33.3%. In contrast, the proportion of women with a previous negative Pap test less than 5 years and 5 years or more before cancer incidence increased from 5.7 to 13.3% and from 0.3 to 5.5%, respectively. Although nonattendance of the screening programme remains the main barrier to cervical cancer control, the introduction of a more sensitive test, such as the human papillomavirus DNA test, could significantly reduce the burden of disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24787379     DOI: 10.1097/CEJ.0000000000000035

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  4 in total

1.  Clinical Epidemiology of Microinvasive Cervical Carcinoma in an Italian Population Targeted by a Screening Programme.

Authors:  Lauro Bucchi; Silvano Costa; Silvia Mancini; Flavia Baldacchini; Orietta Giuliani; Alessandra Ravaioli; Rosa Vattiato; Federica Zamagni; Paolo Giorgi Rossi; Cinzia Campari; Debora Canuti; Priscilla Sassoli de Bianchi; Stefano Ferretti; Fabio Falcini
Journal:  Cancers (Basel)       Date:  2022-04-22       Impact factor: 6.575

2.  Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter.

Authors:  P Giorgi Rossi; C Fortunato; P Barbarino; S Boveri; S Caroli; A Del Mistro; A Ferro; C Giammaria; M Manfredi; T Moretto; A Pasquini; M Sideri; M C Tufi; C Cogo; E Altobelli
Journal:  Br J Cancer       Date:  2015-01-29       Impact factor: 7.640

Review 3.  Cancer prevention: state of the art and future prospects.

Authors:  I Valle; D Tramalloni; N L Bragazzi
Journal:  J Prev Med Hyg       Date:  2015-06-10

4.  Association between mothers' screening uptake and daughters' HPV vaccination: a quasi-experimental study on the effect of an active invitation campaign.

Authors:  Francesco Venturelli; Flavia Baldacchini; Cinzia Campari; Cinzia Perilli; Maria Grazia Pascucci; Alba Carola Finarelli; Luigi Moscara; Paolo Giorgi Rossi
Journal:  BMJ Open       Date:  2017-09-25       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.